Abstract Details

Title Frequency of Post Stroke Shoulder Pain

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) P02 - (-)

Poster/Presentation
Number 030

Objective

Background BACKGROUND: Shoulder pain is known to retard rehabilitation after stroke. Its causes and prognosis are uncertain. This study describes the incidence of post stroke shoulder pain prospectively, in an unselected stroke population in the first 3 months after stroke.

Design/Methods DESIGN/METHODS: The 92 patients entered the study. 88 of them, mean age of 70.6 years, was examined at 2 weeks, 4, and 3 months after stroke. The data about shoulder pain, Barthel index, anxiety and depression score were recorded. Full neurological examination was undertaken, using the contra lateral side as a control. Pain outcome and stroke outcome was recorded at subsequent visits.NSAID treatment is used to all patients, in order to treat the pain.

Results RESULTS: 35 (40%) patients developed shoulder pain on the same side of their stroke. There was a strong association between pain and abnormal shoulder joint examination, ipsi lateral sensory abnormalities and arm weakness. Shoulder pain had resolved or improved at 3 months in 70 (80%) of the patients with NSAID.

Conclusions CONCLUSIONS: Shoulder pain after stroke occurred in 40% of 88 patients surviving, consenting to participate. Eighty percent of patients made a good recovery with NSAID Patients with sensory and or motor deficits represent at risk sub-groups. There was no difference between gender.

Authors/Disclosures
Drini Dobi, MD, PhD (UHC Mother Teresa) PRESENTER	No disclosure on file
Aksel Siva, MD (Istanbul University Cerrahpasa School of Medicine)	Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Mira Kapisyzi, DO	No disclosure on file
Jera Kruja, MD (Bayer Pharma d.o.o Representative Office Alba)	Dr. Kruja has nothing to disclose.

��ɫ��

��ɫ��